JSCPT 2026

Richmond Pharmacology is excited to join the JSCPT Annual Meeting 2026 in Tokyo, Japan, on 27-28 November 2026.

Bringing together experts in clinical pharmacology and therapeutics, this meeting serves as a key platform for advancing drug development, optimizing clinical trial methodologies, and fostering global collaboration in clinical research.

Representing Richmond Pharmacology

• Dr Jörg Taubel, Chief Executive Officer

• Dr Ulrike Lorch, Chief Medical Director

• Stephen Wilkinson, Business Development Manager

• Nobuo Ittetsu, Head of Japanese Volunteer Recruitment

• Minoru Takada, Japanese Business Development Executive

We look forward to connecting with attendees to discuss Richmond’s expertise in:

• Advances in clinical pharmacology and therapeutic innovation

• Optimizing trial design for complex drug development programs

• Regulatory pathways for novel therapies

• Patient-centric approaches and recruitment strategies

• Collaboration between academia, industry, and regulators

Connect With Us

If you are attending JSCPT Annual Meeting 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

‍